[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624687":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":32,"responsibleParty":53,"collaborators":18,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":18,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":18,"overallStatus":74,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Fundacion Clinic per a la Recerca Biomédica","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","EXPERIMENTAL","Group that will undergo a multinodal intervention in the sexual sphere and lifestyle",[13],"Drug: Sex hormones and modulators of the genital system.",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Arm","NO_INTERVENTION","Control group according to routine clinical practice",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DRUG","Sex hormones and modulators of the genital system.","To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle.",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Laura B Burunat, Graduate","CONTACT","+342275400","4198","burunat@recerca.clinic.cat",[33],{"facility":34,"status":18,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Laura Burunat","Teià","Barcelona","08329","Spain","ES",{"type":41,"coordinates":42},"Point",[43,44],2.32206,41.49804,{"lat":44,"lon":43},[47,50],{"name":48,"role":28,"phone":49,"phoneExt":30,"email":31},"Laura B Burunat, Chemistry","0034932275400",{"name":51,"role":52,"phone":18,"phoneExt":18,"email":18},"Berta D Diaz, MDPhD","PRINCIPAL_INVESTIGATOR",{"type":54,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100624687","phase-4-study-on-sexual-health-and-self-perceived-quality-of-life-proms-in-patients-treated-for-cervical-cancer-100624687",false,"NCT07412873","Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer","Prospective Randomized Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer","PROVIDENCE","Inclusion Criteria:\n\n* Women of legal age.\n* Patients with primary cervical cancer stage FIGO I-III (initial or locally advanced) of squamous histology, adenocarcinoma or adenosquamous.\n* Patients treated for cancer with surgery and\u002For radiotherapy ± systemic treatment in the Gynaecological Oncology Units of hospitals in Spain.\n* Complete response after oncospecific treatment was obtained.\n* Signature of the informed consent (IC) by the patient or responsible family member.\n\nExclusion Criteria:\n\n* Patients under 18 years of age.\n* Pregnancy or breastfeeding.\n* Partial response after completion of oncospecific treatment.\n* Patients with premalignant pathology.\n* Diagnosis of a tumor of non-cervical origin or atypical histologies.\n* Impossibility of completing the questionnaires included in the protocol autonomously.\n* Contraindications to the use of vaginal estrogens.\n* Patients undergoing fertility-sparing treatment (trachelectomy or conization).\n* Patients undergoing palliative treatment.","FEMALE","18 Years",{"count":66,"type":67},120,"ESTIMATED","INTERVENTIONAL",[70],"PHASE4","To assess the improvement in sexual function and self-perceived quality of life using PROMs (Patient-Reported Outcomes) in patients treated for cervical cancer who undergo a multimodal intervention in the sexual sphere and lifestyle compared to those who undergo care within routine clinical practice.",[73],"Cervical Cancer","NOT_YET_RECRUITING","2026-02-09",{"date":77,"type":78},"2026-02-17","ACTUAL",{"date":80,"type":67},"2026-03-02",{"date":82,"type":67},"2029-06-30",{"name":5,"class":6},1]